0	12	Epstein-Barr	epstein-barr	JJ
13	18	virus	virus	NN
19	26	binding	bind	VBG
27	29	to	to	TO
30	34	CD21	CD21	NNP
35	44	activates	activate	VBZ
45	48	the	the	DT
49	56	initial	initial	JJ
57	62	viral	viral	JJ
63	71	promoter	promoter	NN
72	75	via	via	IN
76	85	NF-kappaB	NF-kappaB	NNP
86	95	induction	induction	NN
95	96	.	.	.

98	110	Epstein-Barr	epstein-barr	JJ
111	116	virus	virus	NN
117	118	(	(	(
118	121	EBV	EBV	NNP
121	122	)	)	)
122	123	,	,	,
124	126	an	an	DT
127	136	oncogenic	oncogenic	JJ
137	142	human	human	JJ
143	154	herpesvirus	herpesvirus	NN
154	155	,	,	,
156	161	binds	bind	VBZ
162	164	to	to	TO
165	168	and	and	CC
169	176	infects	infect	VBZ
177	183	normal	normal	JJ
184	189	human	human	JJ
190	191	B	b	NN
192	203	lymphocytes	lymphocyte	NNS
204	207	via	via	IN
208	212	CD21	CD21	NNP
212	213	,	,	,
214	217	the	the	DT
218	221	CR2	cr2	NN
222	232	complement	complement	NN
233	241	receptor	receptor	NN
241	242	.	.	.

243	250	Studies	study	NNS
251	253	of	of	IN
254	257	the	the	DT
258	268	mechanisms	mechanism	NNS
269	273	that	that	WDT
274	280	enable	enable	VBP
281	284	EBV	EBV	NNP
285	287	to	to	TO
288	294	infect	infect	VB
295	307	nonactivated	nonactivated	JJ
307	308	,	,	,
309	319	noncycling	noncycling	JJ
320	321	B	B	NNP
322	327	cells	cell	NNS
328	335	provide	provide	VBP
336	346	compelling	compelling	JJ
347	355	evidence	evidence	NN
356	359	for	for	IN
360	361	a	a	DT
362	370	sequence	sequence	NN
371	373	of	of	IN
374	380	events	event	NNS
381	383	in	in	IN
384	389	which	which	WDT
390	393	EBV	EBV	NNP
394	401	binding	bind	VBG
402	404	to	to	TO
405	409	CD21	cd21	NN
410	412	on	on	IN
413	421	purified	purify	VBN
422	429	resting	rest	VBG
430	435	human	human	JJ
436	437	B	B	NNP
438	443	cells	cell	NNS
444	451	rapidly	rapidly	RB
452	461	activates	activate	VBZ
462	465	the	the	DT
466	475	NF-kappaB	NF-kappaB	NNP
476	489	transcription	transcription	NN
490	496	factor	factor	NN
496	497	,	,	,
498	503	which	which	WDT
503	504	,	,	,
505	507	in	in	IN
508	512	turn	turn	NN
512	513	,	,	,
514	519	binds	bind	VBZ
520	522	to	to	TO
523	526	and	and	CC
527	535	mediates	mediate	VBZ
536	551	transcriptional	transcriptional	JJ
552	562	activation	activation	NN
563	565	of	of	IN
566	568	Wp	Wp	NNP
568	569	,	,	,
570	573	the	the	DT
574	581	initial	initial	JJ
582	587	viral	viral	JJ
588	594	latent	latent	JJ
595	599	gene	gene	NN
600	608	promoter	promoter	NN
608	609	.	.	.

610	614	Thus	thus	RB
614	615	,	,	,
616	619	EBV	EBV	NNP
620	627	binding	bind	VBG
628	630	to	to	TO
631	634	its	its	PRP$
635	643	cellular	cellular	JJ
644	652	receptor	receptor	NN
653	655	on	on	IN
656	663	resting	rest	VBG
664	665	B	B	NNP
666	671	cells	cell	NNS
672	680	triggers	trigger	VBZ
681	683	an	an	DT
684	703	NF-kappaB-dependent	nf-kappab-dependent	JJ
704	717	intracellular	intracellular	JJ
718	727	signaling	signaling	NN
728	735	pathway	pathway	NN
736	741	which	which	WDT
742	744	is	be	VBZ
745	753	required	require	VBN
754	757	for	for	IN
758	767	infection	infection	NN
767	768	.	.	.